We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$61.1M
AUM Growth
-$266K
Cap. Flow
-$5.25M
Cap. Flow %
-8.59%
Top 10 Hldgs %
31.78%
Holding
108
New
30
Increased
19
Reduced
22
Closed
32

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$1.88M
2
AET
Aetna Inc
AET
+$1.8M
3
BAX icon
Baxter International
BAX
+$1.22M
4
MCK icon
McKesson
MCK
+$1.04M
5
UNH icon
UnitedHealth
UNH
+$1.03M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$2.28M
2
AGN
Allergan plc
AGN
+$1.83M
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.81M
4
AAPL icon
Apple
AAPL
+$1.65M
5
GILD icon
Gilead Sciences
GILD
+$1.6M

Sector Composition

Rank Sector Weight
1 Healthcare 40.86%
2 Technology 8.54%
3 Communication Services 4.28%
4 Financials 4.21%
5 Energy 3.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRUS icon
26
Cirrus Logic
CRUS
$6.74B
$895K 1.46%
23,076
+18,449
+399% +$662K
MSFT icon
27
Microsoft
MSFT
$3.69T
$887K 1.45%
17,341
-6,313
-27% -$328K
HRTX icon
28
Heron Therapeutics
HRTX
$98.9M
$871K 1.42%
48,279
-770
-2% -$15K
BDX icon
29
Becton Dickinson
BDX
$46.8B
$835K 1.37%
5,047
+1,888
+60% +$302K
VISN
30
Vistance Networks Inc
VISN
$2.8B
$821K 1.34%
+26,464
New +$785K
CBRE icon
31
CBRE Group
CBRE
$43.6B
$788K 1.29%
29,774
+22,130
+290% +$647K
AERI
32
DELISTED
Aerie Pharmaceuticals
AERI
$780K 1.28%
44,345
-2,720
-6% -$44K
AR icon
33
Antero Resources
AR
$11B
$770K 1.26%
+29,620
New +$808K
HLF icon
34
Herbalife
HLF
$1.34B
$765K 1.25%
26,138
+9,232
+55% +$276K
UHS icon
35
Universal Health Services
UHS
$10B
$685K 1.12%
5,105
-6,082
-54% -$802K
HAL icon
36
Halliburton
HAL
$27.1B
$683K 1.12%
+15,080
New +$620K
PBYI icon
37
Puma Biotechnology
PBYI
$397M
$677K 1.11%
+22,740
New +$711K
BMY icon
38
Bristol-Myers Squibb
BMY
$135B
$669K 1.09%
9,099
-25,588
-74% -$1.81M
PANW icon
39
Palo Alto Networks
PANW
$294B
$666K 1.09%
32,562
-19,044
-37% -$441K
REGN icon
40
PUT
Regeneron Pharmaceuticals
REGN
$78.4B
$664K 1.09%
+1,900
New +$732K
HOLX
41
DELISTED
Hologic
HOLX
$651K 1.06%
18,827
+9,633
+105% +$334K
JAZZ icon
42
CALL
Jazz Pharmaceuticals
JAZZ
$16.4B
$579K 0.95%
4,100
-200
-5% -$29.5K
OEF icon
43
PUT
iShares S&P 100 ETF
OEF
$20.5B
$489K 0.8%
+1,900
New +$175K
DVN icon
44
Devon Energy
DVN
$50.8B
$462K 0.76%
+12,741
New +$432K
BABA icon
45
Alibaba
BABA
$309B
$444K 0.73%
5,585
+2,816
+102% +$220K
CLVS
46
DELISTED
Clovis Oncology, Inc.
CLVS
$431K 0.71%
31,406
-539
-2% -$7.88K
BPMC
47
DELISTED
Blueprint Medicines
BPMC
$406K 0.66%
20,049
+1,261
+7% +$22.9K
ELGX
48
DELISTED
Endologix Inc
ELGX
$396K 0.65%
+3,180
New +$366K
ARAY icon
49
Accuray
ARAY
$36.6M
$377K 0.62%
72,684
-6,199
-8% -$33.9K
THC icon
50
Tenet Healthcare
THC
$20.4B
$363K 0.59%
+13,136
New +$388K
1
2
3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Partner Investment Management held 108 positions worth $61.1M, down 0.43% from $61.4M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Partner Investment Management withdrew a net $5.25M in Q2 2016, closing 32 positions and reducing 22 holdings. Its most notable exit was Allergan plc, an estimated $1.83M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Partner Investment Management opened a new position in Biogen worth $1.73M.

  • Partner Investment Management's largest Q2 2016 buy was Biogen: 7,139 shares worth $1.73M.
  • Partner Investment Management added most to Aetna Inc in Q2 2016, an estimated $1.8M increase.
  • Partner Investment Management's biggest Q2 2016 reduction was HCA Healthcare, cutting an estimated $2.28M.
  • Partner Investment Management fully exited Allergan plc in Q2 2016, selling an estimated $1.83M.
  • Partner Investment Management's ten largest holdings make up 32% of its $61.1M portfolio in Q2 2016.
  • Partner Investment Management opened 30 new positions and closed 32 in Q2 2016.
  • Partner Investment Management's portfolio value fell 0.43% quarter-over-quarter to $61.1M.

Based on Partner Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.